Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Jul;73(3):779–785. doi: 10.1111/j.1476-5381.1981.tb16815.x

Site of analgesic action of a non-steroidal, anti-inflammatory drug, tolmetin sodium, in rats.

H Nakamura, M Shimizu
PMCID: PMC2071701  PMID: 7248666

Abstract

1 The site of the analgesic action of tolmetin sodium was investigated by use of the acetic acid writhing test in rats. 2 Tolmetin sodium was administered to the rat between 15 and 60 min after intraperitoneal injection of 1 ml of a 1% acetic acid aqueous solution. Number of writhing was counted for 20 min beginning from 60 min after acetic acid injection. 3 When the rat was given tolmetin sodium 5 mg/kg orally, a relatively large quantity of tolmetin was found in the peritoneal exudate and there was a rough correlation between anti-writhing activity and the exudate tolmetin content. 4 Anti-writhing ED50 of tolmetin sodium was 1.42 (0.82-2.91) and 92.0 (57.0-140) microgram/kg when given intraperitoneally and intravenously, respectively, and the potency ratio of intraperitoneal to intravenous tolmetin sodium was 40.0 (18.5-80.2). This potency ratio for salicylic acid and morphine hydrochloride was 19.4 and 1.0, respectively. 5 When equipotent doses ( 5 microgram/kg i.p.; 200 microgram/kg i.v.) of tolmetin sodium were administered to the rat, the plasma tolmetin level after the intraperitoneal administration was less than one-fortieth that after the intravenous administration during the counting time of 20 min, while both the peritoneal exudate contents of tolmetin were nearly equal. 6 From these results, it is concluded that the site of anti-writhing action of tolmetin sodium is in the peritoneum and that tolmetin sodium produces its anti-writhing action mainly by a peripheral mechanism in the rat.

Full text

PDF
779

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAN T. ELECTROENCEPHALOGRAPHIC STUDIES OF ANTIPYRETIC ANALGESICS. 2. THE EFFECT OF AMINOPYRINE ON THE RABBIT. Jpn J Pharmacol. 1963 Apr;13:104–121. doi: 10.1254/jjp.13.104. [DOI] [PubMed] [Google Scholar]
  2. Berkowitz S. S., Bernhard G., Bilka P. J., Blechman W. J., Marchesano J. M., Rosenthal M., Wortham G. F. Tolmetin versus placebo for the treatment of rheumatoid arthritis: a sequential double-blind clinical trial. Curr Ther Res Clin Exp. 1974 May;16(5):442–451. [PubMed] [Google Scholar]
  3. Dubas T. C., Parker J. M. A central component in the analgesic action of sodium salicylate. Arch Int Pharmacodyn Ther. 1971 Nov;194(1):117–122. [PubMed] [Google Scholar]
  4. GUZMAN F., BRAUN C., LIM R. K., POTTER G. D., RODGERS D. W. NARCOTIC AND NON-NARCOTIC ANALGESICS WHICH BLOCK VISCERAL PAIN EVOKED BY INTRA-ARTERIAL INJECTION OF BRADYKININ AND OTHER ALGESIC AGENTS. Arch Int Pharmacodyn Ther. 1964 Jun 1;149:571–588. [PubMed] [Google Scholar]
  5. HASHIMOTO K., KUMAKURA S., TAIRA N. VASCULAR REFLEX RESPONSES INDUCED BY AN INTRAARTERIAL INJECTION OF AZAAZEPINOPHENOTHIAZINE, ANDROMEDOTOXIN, VERATRIDINE, BRADYKININ AND KALLIKREIN AND BLOCKING ACTION OF SODIUM SALICYLATE. Jpn J Physiol. 1964 Jun 15;14:299–308. doi: 10.2170/jjphysiol.14.299. [DOI] [PubMed] [Google Scholar]
  6. Hashimoto M., Miyazaki H., Fujii T., Nambu K., Tanaka K. Studies on disposition and metabolism of tolmetin, a new anti-inflammatory agent, in rats and mice. I. Absorption, distribution, and excrection of [14C]tolmetin radioactivity. Drug Metab Dispos. 1979 Jan-Feb;7(1):14–19. [PubMed] [Google Scholar]
  7. Hirata M., Tanaka S., Taira N., Hashimoto K. Comparative studies on pseudaffective responses to different algesic substances in conscious dogs. The effect of sodium salicylate. Arch Int Pharmacodyn Ther. 1966 Jul;162(1):150–161. [PubMed] [Google Scholar]
  8. LIM R. K., GUZMAN F., RODGERS D. W., GOTO K., BRAUN C., DICKERSON G. D., ENGLE R. J. SITE OF ACTION OF NARCOTIC AND NON-NARCOTIC ANALGESICS DETERMINED BY BLOCKING BRADYKININ-EVOKED VISCERAL PAIN. Arch Int Pharmacodyn Ther. 1964 Nov 1;152:25–58. [PubMed] [Google Scholar]
  9. Maibach E. European experiences with tolmetin in the treatment of rheumatic diseases. Curr Ther Res Clin Exp. 1976 Mar;19(3):350–362. [PubMed] [Google Scholar]
  10. Nakamura H., Ishii K., Motoyoshi S., Imazu C., Yokoyama Y., Shimizu M. [Analgesic activity of a non-steroidal anti-inflammatory agent, tolmetin sodium in experimental animals (author's transl)]. Nihon Yakurigaku Zasshi. 1979 May;75(4):405–417. doi: 10.1254/fpj.75.405. [DOI] [PubMed] [Google Scholar]
  11. Nakamura H., Yokoyama Y., Motoyoshi S., Ishii K., Shimizu M. [Effect of a non-steroidal anti-inflammatory agent, tolmetin sodium on exudative inflammation in experimental animals (author's transl)]. Nihon Yakurigaku Zasshi. 1979 Jul;75(5):447–458. doi: 10.1254/fpj.75.447. [DOI] [PubMed] [Google Scholar]
  12. Niemegeers C. J., Van Bruggen J. A., Janssen P. A. Suprofen, a potent antagonist of acetic acid-induced writhing in rats. Arzneimittelforschung. 1975 Oct;25(10):1505–1509. [PubMed] [Google Scholar]
  13. Sasa M., Fukuda N., Takaori S. Effects of aminopyrine and phenylbutazone on the activity of neurons in the trigeminal nuclei and hypothalamus. Jpn J Pharmacol. 1969 Sep;19(3):363–372. doi: 10.1254/jjp.19.363. [DOI] [PubMed] [Google Scholar]
  14. Taira N., Nakayama K., Hashimoto K. Vocalization response of puppies to intra-arterial administration of bradykinin and other algesic agents, and mode of actions of blocking agents. Tohoku J Exp Med. 1968 Dec;96(4):365–377. doi: 10.1620/tjem.96.365. [DOI] [PubMed] [Google Scholar]
  15. WINDER C. V. Aspirin and algesimetry. Nature. 1959 Aug 15;184:494–497. doi: 10.1038/184494a0. [DOI] [PubMed] [Google Scholar]
  16. Wong S., Gardocki J. F., Pruss T. P. Pharmacologic evaluation of tolectin (tolmetin, mcn-2559) and mcn-2891, two anti-inflammatory agents. J Pharmacol Exp Ther. 1973 Apr;185(1):127–138. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES